# Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients

> **NCT05148949** · PHASE4 · UNKNOWN · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 240 (estimated)

## Conditions studied

- COVID-19
- Pulmonary Tuberculosis

## Interventions

- **BIOLOGICAL:** Standard dosage inactivated vaccine
- **BIOLOGICAL:** Double dosage inactivated vaccine

## Key facts

- **NCT ID:** NCT05148949
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-22
- **Primary completion:** 2022-12-10
- **Final completion:** 2023-03-10
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2022-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05148949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05148949, "Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05148949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*